Showing results (241-250 of 329) with videos related to

Sort By:
Pageof 33
Cancer Research|January 19, 1999
A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancerY K Tran, O Bögler, K M Gorse, et al.
The Journal of Cell Biology|June 2, 1997
Targeting of U2AF65 to sites of active splicing in the nucleusM Gama-Carvalho, R D Krauss, L Chiang, et al.
Nucleic Acids Research|September 25, 1984
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoterD A Melton, P A Krieg, M R Rebagliati, et al.
Molecular and Cellular Biology|October 1, 1988
A common trans-acting factor is involved in transcriptional regulation of neurotransmitter genes by cyclic AMPS E Hyman, M Comb, Y S Lin, et al.
Nature|July 23, 1992
Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2S J Kim, S Wagner, F Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 1994
Alternating irradiation and chemotherapy in stage III A and B nonsmall cell lung cancer: report of a cancer and Leukemia Group B phase II study 8636S L Seagren, J E Herndon, J R Baeker, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group BH L Kindler, F Millard, J E Herndon, et al.
Oncology (Williston Park, N.Y.)|April 17, 2001
Irinotecan/gemcitabine combination chemotherapy in pancreatic cancerC M Rocha Lima, C A Sherman, F J Brescia, et al.
Cancer|October 15, 1985
Applications and limitations of peripheral blood lymphocyte immunoglobulin light chain analysis in the evaluation of non-Hodgkin's lymphomaR E Sobol, R O Dillman, H Collins, et al.
Chest|March 27, 1998
Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group BJ E Herndon, M R Green, A P Chahinian, et al.
Pageof 33